Entity Details

Primary name SEMA6B
Entity type gene
Source Source Link

Details

PrimaryID10501
RefseqGene
SymbolSEMA6B
Namesemaphorin 6B
Chromosome19
Location19p13.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1999-07-06
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsSEM6B_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001755 neural crest cell migration
GO:0005615 extracellular space
GO:0005887 integral component of plasma membrane
GO:0007411 axon guidance
GO:0007417 central nervous system development
GO:0021766 hippocampus development
GO:0030215 semaphorin receptor binding
GO:0030335 positive regulation of cell migration
GO:0045499 chemorepellent activity
GO:0048843 negative regulation of axon extension involved in axon guidance
GO:0050919 negative chemotaxis
GO:0071526 semaphorin-plexin signaling pathway

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618876 OMIMEpilepsy, progressive myoclonic 11 (EPM11)A form of progressive myoclonic epilepsy, a clinically and genetically heterogeneous group of disorders defined by the combination of action and reflex myoclonus, other types of epileptic seizures, and progressive neurodegeneration and neurocognitive impairment. EPM11 is an autosomal dominant form. Clinical features include normal or mildly delayed early development, developmental regression after seizures onset, inability to walk, severely impaired intellectual development, poor or absent speech, spasticity, ataxia, and intention tremor. Brain imaging shows cerebellar atrophy in some patients. The disease is caused by variants affecting the gene represented in this entry.

Interactions

1 interaction

InteractorPartnerSourcesPublicationsLink
SEMA6BDDX58BioGRID32513696 details